Drug Shortage Report for TEVA-SOLIFENACIN
| Report ID | 149113 |
| Drug Identification Number | 02397900 |
| Brand name | TEVA-SOLIFENACIN |
| Common or Proper name | TEVA-SOLIFENACIN 5MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SOLIFENACIN SUCCINATE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | G04BD |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-11-10 |
| Estimated end date | 2022-04-30 |
| Actual end date | 2022-04-20 |
| Shortage status | Resolved |
| Updated date | 2022-04-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2022-04-21 | French | Compare |
| v11 | 2022-04-21 | English | Compare |
| v10 | 2022-02-24 | French | Compare |
| v9 | 2022-02-24 | English | Compare |
| v8 | 2022-02-10 | French | Compare |
| v7 | 2022-02-10 | English | Compare |
| v6 | 2022-01-27 | French | Compare |
| v5 | 2022-01-27 | English | Compare |
| v4 | 2021-11-25 | French | Compare |
| v3 | 2021-11-25 | English | Compare |
| v2 | 2021-11-11 | French | Compare |
| v1 | 2021-11-11 | English | Compare |
Showing 1 to 12 of 12